These modifications, which are crucial for tumor growth and increase resistance to targeted treatments like EGFR-TKIs, include changes in glycolysis, oxidative phosphorylation, and lipid metabolism in NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.